EUVIMEDEUVIMED entdecken
Open Access

Oral Microbiome and Inferred Functions Predict Kaposi's Sarcoma Progression

Adam Officer, Wen Meng iD, David Spellman, Jeffrey Martin, Paige M Bracci, Mike McGrath, Yufei Huang, Shou-Jiang Gao iD

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Adam Officer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Microbiota, Mouth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health., This study was supported by grants from the National Institutes of Health (CA096512, CA284554, CA278812, CA291244 and CA124332 to S.-J. Gao), UPMC Hillman Canc….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi′s sarcoma (KS) is a common cancer among people living with HIV and is caused by infection with Kaposi′s sarcoma‐associated herpesvirus (KSHV). While previous studies have linked the oral microbiome to KSHV infection and KS development, its role in KS progression remains poorly defined. We performed 16S rRNA gene sequencing targeting the V1‐V2 and V3‐V4 hypervariable regions to characterize the microbiome in 20 patients with AIDS‐associated KS, including 10 with nonprogressive disease and 10 with progressive disease. Samples were obtained from three anatomical sites: oral cavity, peripheral blood, and tumor biopsies. The highest number of microbes were identified in the oral cavity at species, genus, and family levels. Beta diversity analysis revealed significant compositional differences in the oral microbiome between progressive and nonprogressive KS ( p value = 0.044). Differential abundance analysis identified 16 species in the oral cavity associated with disease progression, compared to only three species in tumors and one in blood ( p value < 0.05). Notably, Prevotella pallens and Megasphaera micronuciformis , both known producers of short‐chain fatty acids, were significantly enriched in the oral microbiome of patients with progressive KS (log‐fold changes = 2.8 and 2.4, respectively). Functional pathway inference revealed 39 differentially abundant microbial pathways in the oral cavity, including pathways related to denitrification, ubiquinone biosynthesis, and arginine metabolism (all p values < 0.05). Our findings provide the first evidence that specific oral microbiome alterations are associated with KS progression. The enrichment of short‐chain fatty acid‐producing bacteria and changes in microbial metabolic pathways may promote inflammation and KSHV lytic replication, offering potential mechanistic insights into KS pathogenesis and highlighting novel microbiome‐based prognostic markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, KaposiMicrobiotaMouthHumansDisease ProgressionRNA, Ribosomal, 16SMaleFemaleMiddle AgedAdultHerpesvirus 8, HumanSequence Analysis, DNABacteriaDNA, BacterialDNA, RibosomalAIDS-Related Opportunistic Infections

Stichwörter der Autor:innen

Cancer progressionKSHV lytic replicationKaposi′s sarcomainflammationmicrobiomeoral microbiomeshort‐chain fatty acids

Substanzen

RNA, Ribosomal, 16SDNA, BacterialDNA, Ribosomal

Autor:innen und Institutionen

  • Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Department of Medicine, The University of California at San Francisco, San Francisco, California, USA.
  • Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Wen Meng, Shou-Jiang Gao

Förderung

  • NCI NIH HHS
  • National Institutes of Health.
  • This study was supported by grants from the National Institutes of Health (CA096512, CA284554, CA278812, CA291244 and CA124332 to S.-J. Gao), UPMC Hillman Canc…
  • National Institutes of Health

Zitieren

APA

Officer, A., Meng, W., Spellman, D., Martin, J., Bracci, P. M., McGrath, M., Huang, Y., & Gao, S. J. (2025). Oral Microbiome and Inferred Functions Predict Kaposi's Sarcoma Progression. Journal of Medical Virology. https://doi.org/10.1002/jmv.70647

Vancouver

Officer A, Meng W, Spellman D, Martin J, Bracci PM, McGrath M, et al. Oral Microbiome and Inferred Functions Predict Kaposi's Sarcoma Progression. Journal of Medical Virology. 2025. doi:10.1002/jmv.70647

BibTeX
@article{Officer2025,
  author = {Officer, Adam and Meng, Wen and Spellman, David and Martin, Jeffrey and Bracci, Paige M and McGrath, Mike and Huang, Yufei and Gao, Shou-Jiang},
  title = {Oral Microbiome and Inferred Functions Predict Kaposi's Sarcoma Progression},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70647}
}
Kostenlos starten →